With the mission of providing effective, safe, and internationally standardized pharmaceutical solutions, the leadership team of Audace Pharma, including CEO Nguyen Xuan Hai and Deputy CEO Nguyen Hong Van, paid an official visit to Ha Tinh Pharmaceutical Joint Stock Company (HADIPHAR). This visit serves as a testament to the strong partnership between the two companies, built on trust and shared goals, contributing to sustainable values in the pharmaceutical industry.
HADIPHAR is one of Vietnam’s leading pharmaceutical companies, with over 65 years of experience in pharmaceutical research, production, and functional food manufacturing. In recent years, HADIPHAR and Audace Pharma have worked closely together, achieving significant milestones in the pharmaceutical field, particularly in enhancing product quality, developing new products, and expanding international markets.
Key Highlights of HADIPHAR’s Manufacturing Facilities:
1. Comprehensive Formulation Capabilities: HADIPHAR owns two modern pharmaceutical manufacturing plants meeting international GMP-WHO standards. The company’s laboratory meets GLP standards, its storage facilities comply with GSP requirements, and its distribution system adheres to GDP and GPP standards. Quality management follows ISO 9001:2015 and ISO 13485:2016 certifications.
2. Prestigious Awards and Recognitions: HADIPHAR has been honored with numerous national awards, including:
– First-Class Labor Order
– Second-Class Labor Order
– Third-Class Labor Order
– “Vietnamese Star Medicine” Award for both the company and its products
– “Vietnam Golden Star” Award
Key Strategic Directions Discussed During the Visit:
1. Enhancing product quality and stability to ensure consistent effectiveness and safety.
2. Continuing to develop new products and formulations to cater to the increasingly diverse demands of international markets.
3. Further investing in production technology, with the goal of establishing additional manufacturing facilities that meet GMP-EU standards.
Both Audace Pharma and HADIPHAR agree that product quality and consumer benefits are the core priorities in all activities. The two companies are committed to continued collaboration, sharing values and a common vision to drive sustainable growth in Vietnam’s pharmaceutical industry while strengthening the presence of Vietnamese enterprises in global markets.
This visit and working session mark not only a significant milestone in the partnership between Audace Pharma and HADIPHAR but also open new development opportunities, further elevating Vietnam’s pharmaceutical industry on the global stage.